Log In
Print this Print this

PAR4 antagonist

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionPAR4 antagonist
Molecular Target Protease-activated receptor 4 (PAR4)
Mechanism of ActionProtease-activated receptor 4 (PAR4) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard Indication Cardiovascular (unspecified)
Indication DetailsTreat cardiovascular diseases
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today